The review discusses fifty eight peptides in numerous clinical phases, indicating a sturdy pipeline of peptide therapies targeting PPIs. These strategies open new avenues for treatments customized to combat unique breast most cancers subtypes and glioblastoma by honing in on integrins, fibronectins, and matrix metalloproteinases. This one of a kind https://albertox345lki5.wikilentillas.com/user